Skip to content
MedCompare

Besifloxacin

Infections
Save $1,230/mo
15× cheaper

BESIVANCE ® (besifloxacin ophthalmic suspension) 0.6% is indicated for the treatment of bacterial conjunctivitis caused by susceptible isolates of the following bacteria: Aerococcus viridans* CDC coryneform group G Corynebacterium pseudodiphtheriticum* Corynebacterium striatum* Haemophilus influenza…

United States
$1,320
per month
India
$91
per month
You save
$1,230
93% cheaper in India
30.3K US scripts/yr$37.3M potential annual savings$40M US spend/yr
Building 3D structure…
Drag to rotate · 3D structureC19H21ClFN3O3

SMILES: C1CCN(C[C@@H](C1)N)C2=C(C=C3C(=C2Cl)N(C=C(C3=O)C(=O)O)C4CC4)F

Compare the price
US price$1,320per month
India price$91per month
You save$1,23093% less

Based on 30 units per month. US $44.02 vs India $3.03 per unit.

Total over 1 periodSave $1,230$1,320 → $91
Is travelling to India worth it?

The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.

Medicine savings over 6 months
$7,378
Estimated travel cost
− $2,300
Net savings after travel
$5,078

Even after travel, you could come out ahead by about $5,078.

Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.

The bigger picture

Besifloxacin is filled about 30.3K times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend
$40M
If sourced from India
$2.8M
Potential annual savings
$37.3M
−93%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.